AKRO
Akero Therapeutics Inc
NASDAQ: AKRO · HEALTHCARE · BIOTECHNOLOGY
$54.65
+0.00% today
Updated 2025-12-09
Market cap
$4.50B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.75
Dividend yield
—
52W range
$32 – $57
Volume
2.9M
Akero Therapeutics Inc (AKRO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.35%
ROA
-0.23%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-4.56M | — | — | — |
| 2018 | $0.00 | $-81.71M | — | — | — |
| 2019 | $0.00 | $-43.76M | — | — | — |
| 2020 | $0.00 | $-79.19M | — | — | — |
| 2021 | $0.00 | $-100.74M | — | — | — |
| 2022 | $0.00 | $-112.03M | — | — | — |
| 2023 | $0.00 | $-151.76M | — | — | — |
| 2024 | $0.00 | $-252.06M | — | — | — |